Multi-center study on patient selection for and the oncologic safety of intraoperative radiotherapy (IORT) with the Xoft Axxent® eBx® System for the management of early stage breast cancer in Taiwan.
Hung-Wen LaiLiang-Chih LiuFu OuyangChung-Chin YaoHsiang-Chun JanYa-Herng ChangChi-Wen TuDar-Ren ChenTsui-Fen ChengYen-Dun TzengHuan-Ming HsuMing-Hsin YehYao-Chung WuPo-Sheng YangHung-Bun LamMing-Feng HouFang-Ming ChenPublished in: PloS one (2017)
In real world experience, patients received IORT differed quite significantly with criteria formulated by trials. The preliminary results of IORT in Taiwan showed it is well acceptable by patients and clinicians.